{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:29Z","timestamp":1740135509011,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900764, 81970676"],"award-info":[{"award-number":["81900764, 81970676"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2020YFS0456, 2021JDJQ0043"],"award-info":[{"award-number":["2020YFS0456, 2021JDJQ0043"]}]},{"name":"Luzhou-Southwest Medical University cooperation project","award":["2020LZXNYDJ32"],"award-info":[{"award-number":["2020LZXNYDJ32"]}]},{"name":"Suining First People's Hospital-Southwest Medical University cooperation project","award":["2021SNXNYD01"],"award-info":[{"award-number":["2021SNXNYD01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tumor-related osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by severe hypophosphatemia and osteomalacia. The diagnosis of TIO can be very difficult because of its nonspecific nature of clinical manifestations. Here we reported a case of young TIO patient with \u201cpainful knee joint with difficulty in moving\u201d to improve the clinical diagnosis and treatment levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient\u2019s clinical features were consistent with TIO. A tumor was successfully located in left tibial by <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT, and then was surgically resected. Upon pathologic assessment, the tumor was diagnosed as phosphaturia stromal tumor (PMT) with positive Vim staining. After the surgery, serum phosphate level rapidly recovered and symptoms significantly improved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TIO should be considered in patients with chronically hypophosphorus osteomalacia in the setting of no family history. Early removal of the responsible tumors is clinically essential for the treatment, and imaging examination is of great significance for tumor localization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01078-4","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T13:05:05Z","timestamp":1657285505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-induced osteomalacia characterized by \u201cpainful knee joint with difficulty in moving\u201d: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Lan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Qing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Lin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pi-Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-6252","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"5","key":"1078_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2169\/internalmedicine.56.7565","volume":"56","author":"Y Takashi","year":"2017","unstructured":"Takashi Y, Kinoshita Y, Ito N, Taguchi M, Takahashi M, Egami N, et al. Tumor-induced Osteomalacia caused by a parotid tumor. Intern Med. 2017;56(5):535\u20139.","journal-title":"Intern Med"},{"key":"1078_CR2","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, et al. Tumour-induced osteomalacia. Nat Rev Dis Primers. 2017;3:17044.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1078_CR3","first-page":"33","volume":"16","author":"RA McCance","year":"1947","unstructured":"McCance RA. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med. 1947;16(1):33\u201346.","journal-title":"Q J Med"},{"issue":"1","key":"1078_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced Osteomalacia. Calcif Tissue Int. 2021;108(1):128\u201342.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"1078_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","volume":"64","author":"J Feng","year":"2017","unstructured":"Feng J, Jiang Y, Wang O, Li M, Xing X, Huo L, et al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J. 2017;64(7):675\u201383.","journal-title":"Endocr J"},{"issue":"6","key":"1078_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11926-015-0512-5","volume":"17","author":"AH Hautmann","year":"2015","unstructured":"Hautmann AH, Hautmann MG, K\u00f6lbl O, Herr W, Fleck M. Tumor-induced Osteomalacia: an up-to-date review. Curr Rheumatol Rep. 2015;17(6):512.","journal-title":"Curr Rheumatol Rep"},{"key":"1078_CR7","first-page":"729387","volume":"2014","author":"AH Hautmann","year":"2014","unstructured":"Hautmann AH, Schroeder J, Wild P, Hautmann MG, Huber E, Hoffstetter P, et al. Tumor-induced Osteomalacia: increased level of FGF-23 in a patient with a Phosphaturic Mesenchymal tumor at the tibia expressing Periostin. Case Rep Endocrinol. 2014;2014:729387.","journal-title":"Case Rep Endocrinol"},{"issue":"1","key":"1078_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"M Kuro-O","year":"2019","unstructured":"Kuro-O M. The Klotho proteins in health and disease. Nat Rev Nephrol. 2019;15(1):27\u201344.","journal-title":"Nat Rev Nephrol"},{"key":"1078_CR9","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.bonr.2018.100192","volume":"10","author":"Y Kinoshita","year":"2019","unstructured":"Kinoshita Y, Takashi Y, Ito N, Ikegawa S, Mano H, Ushiku T, et al. Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets\/osteomalacia (TIO). Bone Rep. 2019;10:100192.","journal-title":"Bone Rep"},{"issue":"1","key":"1078_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1681\/ASN.2014101030","volume":"27","author":"MC Hu","year":"2016","unstructured":"Hu MC, Shi M, Zhang J, Addo T, Cho HJ, Barker SL, et al. Renal production, uptake, and handling of circulating \u03b1Klotho. J Am Soc Nephrol. 2016;27(1):79\u201390.","journal-title":"J Am Soc Nephrol"},{"key":"1078_CR11","doi-asserted-by":"crossref","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1).","DOI":"10.1097\/00000478-200401000-00001"},{"key":"1078_CR12","first-page":"3","volume":"7","author":"R Kumar","year":"2015","unstructured":"Kumar R, Folpe AL, Mullan BP. Tumor-induced Osteomalacia. Transl. Endocrinol Metab. 2015;7:3.","journal-title":"Endocrinol Metab"},{"issue":"10","key":"1078_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, et al. Phosphaturic Mesenchymal tumors: Clinicopathologic, Immunohistochemical and molecular analysis of 22 cases expanding their morphologic and Immunophenotypic Spectrum. Am J Surg Pathol. 2017;41(10):1371\u201380.","journal-title":"Am J Surg Pathol"},{"key":"1078_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","volume":"16","author":"Z-j Sun","year":"2015","unstructured":"Sun Z-j, Jin J, Qiu G-x, Gao P, Liu Y. Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors. BMC Musculoskelet Disord. 2015;16:43.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"1078_CR15","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, et al. Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res. 2013;28(6):1386\u201398.","journal-title":"J Bone Miner Res"},{"key":"1078_CR16","doi-asserted-by":"crossref","unstructured":"Kawai S, Ariyasu H, Furukawa Y, Yamamoto R, Uraki S, Takeshima K, et al. Effective localization in tumor-induced osteomalacia using Ga-DOTATOC-PET\/CT, venous sampling and 3T-MRI. Endocrinol Diabetes Metab Case Rep. 2017;2017.","DOI":"10.1530\/EDM-17-0005"},{"issue":"6","key":"1078_CR17","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res. 2011;26(6):1295\u2013302.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1078_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s43465-019-00005-5","volume":"54","author":"AS Kawthalkar","year":"2020","unstructured":"Kawthalkar AS, Janu AK, Deshpande MS, Gala KB, Gulia A, Puri A. Phosphaturic Mesenchymal tumors from head to toe: imaging findings and role of the radiologist in diagnosing tumor-induced Osteomalacia. Indian J Orthop. 2020;54(2):215\u201323.","journal-title":"Indian J Orthop"},{"issue":"1","key":"1078_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2463\/mrms.2011-0006","volume":"12","author":"K Nakanishi","year":"2013","unstructured":"Nakanishi K, Sakai M, Tanaka H, Tsuboi H, Hashimoto J, Hashimoto N, et al. Whole-body MR imaging in detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced hypophosphatemic osteomalacia. Magn Reson Med Sci. 2013;12(1):47\u201352.","journal-title":"Magn Reson Med Sci"},{"issue":"4","key":"1078_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1067\/j.cpradiol.2018.06.005","volume":"48","author":"M Yang","year":"2019","unstructured":"Yang M, Doshi KB, Roarke MC, Nguyen BD. Molecular imaging in diagnosis of tumor-induced Osteomalacia. Curr Probl Diagn Radiol. 2019;48(4):379\u201386.","journal-title":"Curr Probl Diagn Radiol"},{"key":"1078_CR21","doi-asserted-by":"crossref","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, et al. Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015;40(1).","DOI":"10.1097\/RLU.0000000000000460"},{"issue":"6","key":"1078_CR22","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","volume":"32","author":"D Wild","year":"2005","unstructured":"Wild D, M\u00e4cke HR, Waser B, Reubi JC, Ginj M, Rasch H, et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging. 2005;32(6):724.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1078_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","volume":"64","author":"S Breer","year":"2014","unstructured":"Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, et al. 68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT. Bone. 2014;64:222\u20137.","journal-title":"Bone."},{"issue":"10","key":"1078_CR24","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","volume":"37","author":"I Virgolini","year":"2010","unstructured":"Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37(10):2004\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"1078_CR25","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","volume":"44","author":"M Houang","year":"2013","unstructured":"Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol. 2013;44(12):2711\u20138.","journal-title":"Hum Pathol"},{"issue":"3","key":"1078_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Sch\u00e4r JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27(3):273\u201382.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"1078_CR27","first-page":"500","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics : a review publication of the Radiological Society of North America. Inc. 2015;35(2):500\u201316.","journal-title":"Inc."},{"issue":"3","key":"1078_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2967\/jnumed.109.066662","volume":"51","author":"D Campana","year":"2010","unstructured":"Campana D, Ambrosini V, Pezzilli R, Fanti S, Labate AM, Santini D, et al. Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J Nuclear Med. 2010;51(3):353\u20139.","journal-title":"J Nuclear Med"},{"issue":"2","key":"1078_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/2230-8210.93733","volume":"16","author":"VS Jagtap","year":"2012","unstructured":"Jagtap VS, Sarathi V, Lila AR, Bandgar T, Menon P, Shah NS. Hypophosphatemic rickets. Indian J Endocrinol Metab. 2012;16(2):177\u201382.","journal-title":"Indian J Endocrinol Metab"},{"key":"1078_CR30","doi-asserted-by":"publisher","first-page":"153865","DOI":"10.1016\/j.metabol.2019.01.006","volume":"103S","author":"J Bacchetta","year":"2020","unstructured":"Bacchetta J, Bardet C, Pri\u00e9 D. Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metabolism. 2020;103S:153865.","journal-title":"Metabolism."},{"issue":"1\u20133","key":"1078_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jsbmb.2005.01.024","volume":"94","author":"Y-R Lou","year":"2005","unstructured":"Lou Y-R, Murtola T, Tuohimaa P. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells. J Steroid Biochem Mol Biol. 2005;94(1\u20133):151\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"1078_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/eje.0.1480519","volume":"148","author":"A Enjuanes","year":"2003","unstructured":"Enjuanes A, Garcia-Giralt N, Supervia A, Nogu\u00e9s X, Mellibovsky L, Carbonell J, et al. Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. Eur J Endocrinol. 2003;148(5):519\u201326.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1078_CR33","first-page":"3371","volume":"6","author":"S Swami","year":"2000","unstructured":"Swami S, Krishnan AV, Feldman D. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res. 2000;6(8):3371\u20139.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1078_CR34","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1210\/endo.138.8.5328","volume":"138","author":"XY Zhao","year":"1997","unstructured":"Zhao XY, Ly LH, Peehl DM, Feldman D. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Endocrinology. 1997;138(8):3290\u20138.","journal-title":"Endocrinology."},{"issue":"9","key":"1078_CR35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/BF03350780","volume":"21","author":"R Homburg","year":"1998","unstructured":"Homburg R, Amsterdam A. Polysystic ovary syndrome--loss of the apoptotic mechanism in the ovarian follicles? J Endocrinol Investig. 1998;21(9):552\u20137.","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"1078_CR36","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2007-1650","volume":"93","author":"M Das","year":"2008","unstructured":"Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, et al. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(3):881\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1078_CR37","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.fertnstert.2008.11.031","volume":"93","author":"T Mahmoudi","year":"2010","unstructured":"Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril. 2010;93(4):1208\u201314.","journal-title":"Fertil Steril"},{"issue":"6","key":"1078_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1210\/js.2016-1088","volume":"1","author":"A Nair","year":"2017","unstructured":"Nair A, Chakraborty S, Dharmshaktu P, Tandon N, Gupta Y, Khadgawat R, et al. Peptide receptor radionuclide and Octreotide: a novel approach for metastatic tumor-induced Osteomalacia. J Endocr Soc. 2017;1(6):726\u201330.","journal-title":"J Endocr Soc"},{"issue":"6","key":"1078_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00223-010-9369-9","volume":"86","author":"A Ishii","year":"2010","unstructured":"Ishii A, Imanishi Y, Kobayashi K, Hashimoto J, Ueda T, Miyauchi A, et al. The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels. Calcif Tissue Int. 2010;86(6):455\u201362.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1078_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235\u201353.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"1078_CR41","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/jbmr.401","volume":"26","author":"D Ranch","year":"2011","unstructured":"Ranch D, Zhang MY, Portale AA, Perwad F. Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice. J Bone Miner Res. 2011;26(8):1883\u201390.","journal-title":"J Bone Miner Res"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01078-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T13:05:49Z","timestamp":1657285549000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01078-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"20 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of her clinical details and clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}